(23.46) (C60H108O3Na), 927 [M3 + Na]+ (20.67) (C62H112O3Na), H-3¢), 3.52 (1H, m, H-4¢), 3.22 (1H, dd, J = 12.0; 9.5 Hz, H-5¢), 3.87
955 [M4 + Na]+ (22.66) (C64H116O3Na), 983 [M5 + Na]+ (7.74) (1H, dd, J = 12.0 ; 5.2 Hz, H-5¢). 13C-NMR (100 MHz, CD3OD/TMS),
(C66H120O3Na). 1H-NMR (300 MHz, CDCl3 /TMS): d = 0 .84 (6H, see Table 1.
s, CH3 ±23 and CH3 ±24), 0 .86 (3H, s, CH±30), 0.87 (3H, s,
3
CH3 ±29), 0 .92 (3H, s, CH ±25), 0 .94 (3H, s, CH ±26), 1.14 (3H, 3-O-b-D-Glucopyranosylchondrillasterol 15: Colorless crystals; m.p.
3
3
s, CH3 ±27), 3.20and 3.55 (2H, d, J = 10 .9 Hz, CH±28), 4.50 292±294 8C. [a]D22: ±43.508 (MeOH, c 0.647). IR (KBr): nmax = 3460,
2
(1H, dd, J = 6.0; 10.0 Hz, H-3), 5.17 (1H, t, J = 3.7 Hz, H-12). 2950, 1650, 1110, 970, 840 cm±1. DCI/NH3 MS: m/z = 592 [M +
Long chain; d = 0 .83 (3H, m, terminal CH), 1.23 [br s, (CH2)n], NH4]+, 575 [M + H]+. EI-MS: m/z (rel. int.): = 574 [M]+ (9.2)
3
2.27 (2H, t, J = 7.5 Hz, -CH2-CO2). 13C-NMR (75 MHz, CDCl3): (C35H58O6), 412 [M - Glc]+, 395 (93.5), 311 (14.1), 255 (100.0), 229
d = 15.5 (C-24), 16.7 (C-25), 16.8 (C-26), 18.2 (C-6), 22.0(C-16),
(34.5), 213 (25.8), 187 (17.5), 173 (15.5), 161 (24.5), 147 (34.6), 133
23.5 (C-23), 23.6 (C-30), 25.5 (C-15), 25.9 (C-27), 28.0 (C-2), (30.4), 109 (22.9). 1H-NMR (400 MHz, CD3OD/TMS): d = 0.43 (3H,
29.1 (C-23), 31.0(C-22), 31.9 (C-20), 32.5 (C-7), 33.2 (C-29),
34.0(C-21), 36.8 (C-17), 36.9 (C-10), 37.7 (C-1), 37.7 (C-4), 39.7
s, CH3-18), O.57 (3H, s, CH3±19), 0 .73 (3H, d,J = 6.6 Hz, CH3-26),
0.76 (3H, t, J = 7.1 Hz, CH3-29), 0.80 (3H, d, J = 6.6 Hz, CH3-27),
(C-8), 41.7 (C-14), 42.8 (C-18), 46.4 (C-19), 47.5 (C-9), 55.2 (C-5), 0.94 (3H, d, J = 7.5 Hz, CH3-21), 3.86 (1H, m, H-3), 4.90(1H, ddd,
69.7 (C-28), 80.5 (C-3), 122.3 (C-12), 144.2 (C-13). Long chain; J = 16.0; 7.0 and 7.0 Hz, H-23), 4.95 (1H, dd, J = 16.0and 7.0Hz,
d = 14.1 (terminal CH3), 29.7 [(CH2)n], 36.8 (CH2-CO2), 173.7 H-22), 5.10(1H, t, 8.6 Hz, H-7). Glucose; d = 4.47 (1H, d, J = 7.5
(R-COO).
Hz, H-1¢), 3.28 (1H, dd, J = 9.5; 7.5 Hz, H-2¢), 3.36 (1H, t, J = 9.9
Hz, H-3¢), 3.70(1H, m, H-4 ¢), 3.32 (1H, m, H-5¢), 3.69 (1H, dd,
Methylalkanoates 1a±5a: White powders. GC-MS; (70eV): m/z
+
(rel. int.) = Rt1a 16: 56, 438 [M1a]+ (12.5); Rt2a 17: 58, 466 [M2a
]
(11.2); Rt3a 18: 60, 494 [M3a]+ (9.7); Rt4a 19: 62, 522 [M4a]+ (8.9)
and Rt5a 20: 64, 550 [M5a]+ (7.5).
Table 1 13C-NMR chemical shifts of compounds 12, 13, 14 and 15
No.
12 (DCCl3)
13 (CDCl3)
14 (CD3OD)*
15 (CD3OD)*
b-Amyrin fatty acid esters 6±8: White powders (CDCl3). ES-MS:
m/z (rel. int.) = 743 [M6 + Na]+ (8.5), 771 [M7 + Na]+ (24.3), 799
[M8 + Na]+ (48.5). 1H-NMR (CDCl3/TMS), in accordance to refer-
ence [5].
1
2
3
4
5
6
7
37.1
26.1
38.1
38.8
211.4
44.2
43.0
30.1
117.0
140.4
48.9
34.4
21.7
39.4
43.3
55.0
23.0
28.5
55.9
13.1
12.5
38.2
29.8
79.5
35.2
41.0
30.0
118.7
140.4
50.4
35.6
22.6
40.4
44.3
55.2
24.2
29.8
56.856.8
13.2
13.9
38.2
29.7
79.8
35.3
41.1
30.4
118.8
71.0
34.2
40.2
b-Amyrin acetate 9: Colorless crystals; m.p. 242±2448C; DCI/
1
NH3 MS: m/z = 486 [M + NH4]+; H- and 13C-NMR (CDCl3/TMS),
29.6
117.4
139.5
49.4
see literature [6].
8139.6
Erythrodiol 10: Colorless crystals; m.p. 2378C. [a] 22: + 768
9
50.4
35.7
22.6
40.4
44.4
55.3
24.5
29.8
D
824
10
34.2
(CHCl3, c 0.75). DCI/NH3 MS: m/z = 442 [M + NH4]+. 13C-NMR
11
21.5
(CDCl3), in accordance to reference [7].
12
39.4
13
43.3
28-Hydroxy-12-oleanen-3-one 11: White powder, m.p. 199 8C.
[a]D22:738 (CHCl3, c 1.00). DCI/NH3 MS: m/z = 458 [M + NH4]+.
1H- and 13C-NMR (CDCl3), see literature [8].
14
55.1
15
23.0
16
28.5
17
55.9
Chondrillasterol 12: Colorless crystals; m.p. 163 8C. [a]D22: + 1.78
(CHCl3, c 0.5). DCI/NH3 MS: m/z = 430[M + NH 4]+, 413 [M + H]+.
13C-NMR (CDCl3) (Table 1), in agreement with reference [9].
1812.0
19
12.1
13.0
13.9
20
40.840.840.5
21.1
40.5
21
21.1
138.0
129.6
51.2
22.5
139.6
130.5
52.3
22.5
139.7
130.5
52.5
Chondrillasterone 13: White powder; m.p. 170 8C. [a] 22: + 2.58
22
138.2
129.4
51.2
D
(CHCl3, c 0.8). 13C-NMR (CDCl3), (Table 1); IR, 1H-NMR (CDCl3/
23
TMS), see literature [10].
24
25
31.9
31.9
30.9
30.9
26
19.0
19.0
20.1
20.2
3b-O-b-Xylopyranosylchondrillasterol 14: Colorless crystals; m.p.
282±283 8C. [a]D22: -25.608 (MeOH, c 0.506). IR (KBr): nmax = 3450,
2950, 1645, 1110, 970, 840 cm±1. DCI/NH3 MS: m/z = 562 [M +
NH4]+, 545 [M + H]+. EI-MS: m/z (rel. int.) = 544 [M]+ (11.2)
(C34H56O5), 412 [M - Xyl]+, 395 (90.5), 255 (100.0), 229 (32.5), 213
(25.5),187 (17.5),149 (15.5), 133 (35.4). 1H-NMR (400 MHz, CD3OD/
TMS): d = 0 .44 (3H, s, CH 18), 0 .58 (3H, s, CH ±19), 0.74 (3H, d,
J = 6.6 Hz, CH3 ±26), 0.76 (3H, t, J = 7.1 Hz, CH3 ±29), 0.81 (3H, d,
J = 6.Hz, CH3 ±27), 0.94 (3H, d, J = 7.5 Hz, CH3 ±21), 3.84 (1H, m,
H-3), 4.91 (1H, ddd, J = 16.1; 7.1 and 7.1 Hz, H-23), 4.94 (1H, dd,
J = 16.1 and 7.1 Hz, H-22), 5.10 (1H, t, 8.6 Hz, H-7). Xylose;
d = 4.52 (1H, d, J = 7.0 Hz, H-1¢), 3.34 (1H, m, H-2¢), 3.46 (1H, m,
27
21.4
21.4
22.2
22.3
2825.4
29
25.4
26.6
26.6
12.2
12.4
13.4
13.3
Glucose
103.1
76.1
Sugars
1'
Xylose
105.1
75.1
2'
3±
3
3'
77.0
77.9
4'
70.1
72.6
5'
66.9
76.3
6'
63.7
*Attributions based on DEPT, HSQC and HMBC experiments.
Wandji J et al. Fatty Acid Esters¼ Planta Med 2002; 68: 822±826